Search results

  • 2020

    Remdesivir for the Treatment of Covid-19 - Final Report

    Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., Lopez de Castilla, D., Finberg, R. W., Dierberg, K., Tapson, V., Hsieh, L., Patterson, T. F., Paredes, R., Sweeney, D. A., Short, W. R., Touloumi, G., & 22 othersLye, D. C., Ohmagari, N., Oh, M-D., Ruiz-Palacios, G. M., Benfield, T., Fätkenheuer, G., Kortepeter, M. G., Atmar, R. L., Creech, C. B., Lundgren, J., Babiker, A. G., Pett, S., Neaton, J. D., Burgess, T. H., Bonnett, T., Green, M., Makowski, M., Osinusi, A., Nayak, S., Lane, H. C., ACTT-1 Study Group Members & Nielsen, H., 5 Nov 2020, In: The New England Journal of Medicine. 383, 19, p. 1813-1826 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

    Open Access
    3750 Citations (Scopus)